THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis.
Anastasilakis A, Polyzos S, Makras P.
Eur J Endocrinol. 2018 Jul;179(1):R31-R45.
http://doi.org/10.1530/EJE-18-0056
Epub 2018 Apr 24.